These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 15790310

  • 21. Both p53-PUMA/NOXA-Bax-mitochondrion and p53-p21cip1 pathways are involved in the CDglyTK-mediated tumor cell suppression.
    Yu Z, Wang H, Zhang L, Tang A, Zhai Q, Wen J, Yao L, Li P.
    Biochem Biophys Res Commun; 2009 Sep 04; 386(4):607-11. PubMed ID: 19540190
    [Abstract] [Full Text] [Related]

  • 22. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter.
    Chai YL, Cui J, Shao N, Shyam E, Reddy P, Rao VN.
    Oncogene; 1999 Jan 07; 18(1):263-8. PubMed ID: 9926942
    [Abstract] [Full Text] [Related]

  • 23. Expression of SRG3, a core component of mouse SWI/SNF chromatin-remodeling complex, is regulated by cooperative interactions between Sp1/Sp3 and Ets transcription factors.
    Ahn J, Ko M, Lee K, Oh J, Jeon SH, Seong RH.
    Biochem Biophys Res Commun; 2005 Dec 23; 338(3):1435-46. PubMed ID: 16288722
    [Abstract] [Full Text] [Related]

  • 24. A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis.
    Nagashima M, Shiseki M, Pedeux RM, Okamura S, Kitahama-Shiseki M, Miura K, Yokota J, Harris CC.
    Oncogene; 2003 Jan 23; 22(3):343-50. PubMed ID: 12545155
    [Abstract] [Full Text] [Related]

  • 25. Comparative binding of p53 to its promoter and DNA recognition elements.
    Weinberg RL, Veprintsev DB, Bycroft M, Fersht AR.
    J Mol Biol; 2005 May 06; 348(3):589-96. PubMed ID: 15826656
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ, Chung TW, Kang SK, Lee YC, Ko JH, Kim JG, Kim CH.
    Glycobiology; 2006 Jul 06; 16(7):573-83. PubMed ID: 16574813
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Transcriptional regulation by p53: one protein, many possibilities.
    Laptenko O, Prives C.
    Cell Death Differ; 2006 Jun 06; 13(6):951-61. PubMed ID: 16575405
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
    Phan RT, Dalla-Favera R.
    Nature; 2004 Dec 02; 432(7017):635-9. PubMed ID: 15577913
    [Abstract] [Full Text] [Related]

  • 33. TAT-RasGAP317-326 requires p53 and PUMA to sensitize tumor cells to genotoxins.
    Michod D, Widmann C.
    Mol Cancer Res; 2007 May 02; 5(5):497-507. PubMed ID: 17510315
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Differential effects of phosphorylation of rat p53 on transactivation of promoters derived from different p53 responsive genes.
    Lohrum M, Scheidtmann KH.
    Oncogene; 1996 Dec 19; 13(12):2527-39. PubMed ID: 9000127
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.